Skip to content

Randomized control trial for auto-lipoconcentrate combined with split-thickness skin graft in choronic nonhealing wound

Randomized control trial for auto-lipoconcentrate combined with split-thickness skin graft in choronic nonhealing wound

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020575
Enrollment
Unknown
Registered
2019-01-09
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic nonhealing wound

Interventions

Group 1:auto-lipoconcentrate combined with split thickness skin graft
Group 2:split thickness skin graft

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 81 Years

Inclusion criteria

Inclusion criteria: (1) patients signed the informed consent on the day of the age of 18 or above; (2) a diagnosis of chronic nonhealing wound; (3) ulcer for 2 weeks or more; (4) wound area 3 cm2 or higher; (5) humerus ankle index is between 0.7 to 1.2; (6) stable vital signs, regular examination showed that can tolerate operation; (7) patients' mental state is good who can follow the doctor's advice and visit regularly; (8) understanding and willing to participate in the clinical trials of this item and provide the signed informed consent.

Exclusion criteria

Exclusion criteria: (1) the existing disease affects wound healing (e.g., malignant tumor, autoimmune disease); (2) patients in immunosuppression in screening period because of the underlying disease, long-term immunosuppressive therapy or the use of high doses of corticosteroids (i.e. accept or 40 mg daily prednisone or prednisone amount, for 2 weeks or higher) in screening period; (3) it is difficult to control the high blood sugar (HbA1c > 12.0%); (4) with severe uncontrolled disease or acute systemic infections and merging other serious heart, lung disease, severe encephalopathy and other organs; (5) patients with mental illness; (6) researchers think that should not be included in person; (7) The pregnant women, fertile women without appropriate precautions ,breastfeeding women in the screening period or planing for pregnancy in a month after the end of the study; (8) Being patient to participate in the study at any time in the past.

Design outcomes

Primary

MeasureTime frame
skin survial rate;

Secondary

MeasureTime frame
healing rate;healing quality;

Countries

China

Contacts

Public ContactZhang Jian

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

472294450@qq.com+86 18825136072

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026